PUREfi Wealth LLC Makes New Investment in MeiraGTx Holdings plc (NASDAQ:MGTX)

PUREfi Wealth LLC acquired a new position in MeiraGTx Holdings plc (NASDAQ:MGTX) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 20,000 shares of the company’s stock, valued at approximately $122,000.

Other large investors have also recently bought and sold shares of the company. Knoll Capital Management LLC purchased a new position in shares of MeiraGTx in the third quarter valued at $5,212,000. Royce & Associates LP increased its position in shares of MeiraGTx by 5.3% in the third quarter. Royce & Associates LP now owns 795,392 shares of the company’s stock valued at $3,317,000 after buying an additional 40,000 shares in the last quarter. Erste Asset Management GmbH purchased a new position in shares of MeiraGTx in the third quarter valued at $2,795,000. State Street Corp increased its position in shares of MeiraGTx by 0.9% in the third quarter. State Street Corp now owns 574,727 shares of the company’s stock valued at $2,397,000 after buying an additional 5,251 shares in the last quarter. Finally, Garden State Investment Advisory Services LLC purchased a new position in shares of MeiraGTx in the third quarter valued at $1,636,000. Hedge funds and other institutional investors own 67.48% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently commented on the company. Chardan Capital reiterated a “buy” rating and set a $36.00 price objective on shares of MeiraGTx in a research report on Monday, November 18th. Royal Bank of Canada lifted their price objective on MeiraGTx from $9.00 to $11.00 and gave the stock an “outperform” rating in a research report on Thursday, November 14th.

Insiders Place Their Bets

In other MeiraGTx news, CEO Alexandria Forbes sold 35,839 shares of the firm’s stock in a transaction dated Tuesday, January 7th. The stock was sold at an average price of $6.47, for a total value of $231,878.33. Following the sale, the chief executive officer now directly owns 1,395,102 shares of the company’s stock, valued at approximately $9,026,309.94. This trade represents a 2.50 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Richard Giroux sold 24,000 shares of MeiraGTx stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $6.29, for a total value of $150,960.00. Following the completion of the transaction, the chief financial officer now directly owns 849,947 shares in the company, valued at $5,346,166.63. This represents a 2.75 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 8.40% of the stock is owned by corporate insiders.

MeiraGTx Trading Up 1.5 %

MeiraGTx stock opened at $6.70 on Friday. The stock has a market cap of $523.63 million, a PE ratio of -5.54, a P/E/G ratio of 0.38 and a beta of 1.25. The stock has a 50-day moving average price of $6.25 and a 200 day moving average price of $5.47. MeiraGTx Holdings plc has a 52 week low of $3.85 and a 52 week high of $7.37. The company has a current ratio of 2.34, a quick ratio of 2.34 and a debt-to-equity ratio of 0.86.

MeiraGTx Profile

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia.